Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review.
Identifieur interne : 000055 ( PubMed/Checkpoint ); précédent : 000054; suivant : 000056Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review.
Auteurs : David García-Azorín [Espagne] ; Katrin M. Seeher [Suisse] ; Charles R. Newton [Royaume-Uni] ; Njideka U. Okubadejo [Nigeria] ; Andrea Pilotto [Italie] ; Deanna Saylor [États-Unis] ; Andrea Sylvia Winkler [Allemagne, Norvège] ; Chahnez Charfi Triki [Tunisie] ; Matilde Leonardi [Italie]Source :
- Journal of neurology [ 1432-1459 ] ; 2021.
Abstract
BACKGROUND
The COVID-19 pandemic leads to disruptions of health services worldwide. To evaluate the particular impact on neurological services a rapid review was conducted.
METHODS
Studies reporting the provision of neurological services during the pandemic and/or adopted mitigation strategies were included in this review. PubMed and World Health Organization's (WHO) COVID-19 database were searched. Data extraction followed categories used by WHO COVID-19 pulse surveys and operational guidelines on maintaining essential health services during COVID-19.
FINDINGS
The search yielded 1101 articles, of which 369 fulfilled eligibility criteria, describing data from 210,419 participants, being adults (81%), children (11.4%) or both (7.3%). Included articles reported data from 105 countries and territories covering all WHO regions and World Bank income levels (low income: 1.9%, lower middle: 24.7%, upper middle: 29.5% and high income; 44.8%). Cross-sectoral services for neurological disorders were most frequently disrupted (62.9%), followed by emergency/acute care (47.1%). The degree of disruption was at least moderate for 75% of studies. Travel restrictions due to lockdowns (81.7%) and regulatory closure of services (65.4%) were the most commonly reported causes of disruption. Authors most frequently described telemedicine (82.1%) and novel dispensing approaches for medicines (51.8%) as mitigation strategies. Evidence for the effectiveness of these measures is largely missing.
INTERPRETATION
The COVID-19 pandemic affects all aspects of neurological care. Given the worldwide prevalence of neurological disorders and the potential long-term neurological consequences of COVID-19, service disruptions are devastating. Different strategies such as telemedicine might mitigate the negative effects of the pandemic, but their efficacy and acceptability remain to be seen.
DOI: 10.1007/s00415-021-10588-5
PubMed: 34021772
PubMed Central: PMC8140556
Affiliations:
- Allemagne, Espagne, Italie, Nigeria, Norvège, Royaume-Uni, Suisse, Tunisie, États-Unis
- Angleterre, Bavière, District de Haute-Bavière, Lombardie, Maryland, Oxfordshire, Østlandet
- Milan, Munich, Oslo, Oxford
- Université Louis-et-Maximilien de Munich, Université d'Oxford
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:34021772Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review.</title><author><name sortKey="Garcia Azorin, David" sort="Garcia Azorin, David" uniqKey="Garcia Azorin D" first="David" last="García-Azorín">David García-Azorín</name><affiliation wicri:level="1"><nlm:affiliation>Headache Unit, Department of Neurology. Hospital, Clínico Universitario de Valladolid, Avenida Ramón y Cajal 3, 47005, Valladolid, Spain. dgazorin@ucm.es.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Headache Unit, Department of Neurology. Hospital, Clínico Universitario de Valladolid, Avenida Ramón y Cajal 3, 47005, Valladolid</wicri:regionArea><wicri:noRegion>Valladolid</wicri:noRegion></affiliation></author><author><name sortKey="Seeher, Katrin M" sort="Seeher, Katrin M" uniqKey="Seeher K" first="Katrin M" last="Seeher">Katrin M. Seeher</name><affiliation wicri:level="1"><nlm:affiliation>Department of Mental Health and Substance Use, World Health Organization, Geneve, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Mental Health and Substance Use, World Health Organization, Geneve</wicri:regionArea><wicri:noRegion>Geneve</wicri:noRegion></affiliation></author><author><name sortKey="Newton, Charles R" sort="Newton, Charles R" uniqKey="Newton C" first="Charles R" last="Newton">Charles R. Newton</name><affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, University of Oxford, Oxford, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Psychiatry, University of Oxford, Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region></placeName><orgName type="university">Université d'Oxford</orgName></affiliation></author><author><name sortKey="Okubadejo, Njideka U" sort="Okubadejo, Njideka U" uniqKey="Okubadejo N" first="Njideka U" last="Okubadejo">Njideka U. Okubadejo</name><affiliation wicri:level="1"><nlm:affiliation>Neurology Unit, Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Neurology Unit, Department of Medicine, College of Medicine, University of Lagos, Lagos</wicri:regionArea><wicri:noRegion>Lagos</wicri:noRegion></affiliation></author><author><name sortKey="Pilotto, Andrea" sort="Pilotto, Andrea" uniqKey="Pilotto A" first="Andrea" last="Pilotto">Andrea Pilotto</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Brescia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Brescia</wicri:regionArea><wicri:noRegion>Brescia</wicri:noRegion></affiliation></author><author><name sortKey="Saylor, Deanna" sort="Saylor, Deanna" uniqKey="Saylor D" first="Deanna" last="Saylor">Deanna Saylor</name><affiliation wicri:level="2"><nlm:affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Winkler, Andrea Sylvia" sort="Winkler, Andrea Sylvia" uniqKey="Winkler A" first="Andrea Sylvia" last="Winkler">Andrea Sylvia Winkler</name><affiliation wicri:level="4"><nlm:affiliation>Centre for Global Health, Department of Neurology, Technical University of Munich, Munich, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Centre for Global Health, Department of Neurology, Technical University of Munich, Munich</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName><orgName type="university">Université Louis-et-Maximilien de Munich</orgName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Centre for Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway.</nlm:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Centre for Global Health, Institute of Health and Society, University of Oslo, Oslo</wicri:regionArea><placeName><settlement type="city">Oslo</settlement><region nuts="2">Østlandet</region></placeName></affiliation></author><author><name sortKey="Charfi Triki, Chahnez" sort="Charfi Triki, Chahnez" uniqKey="Charfi Triki C" first="Chahnez" last="Charfi Triki">Chahnez Charfi Triki</name><affiliation wicri:level="1"><nlm:affiliation>Child neurology department-Hedi Chaker Hospital, LR19ES 15-Sfax University, Sfax, Tunisia.</nlm:affiliation><country xml:lang="fr">Tunisie</country><wicri:regionArea>Child neurology department-Hedi Chaker Hospital, LR19ES 15-Sfax University, Sfax</wicri:regionArea><wicri:noRegion>Sfax</wicri:noRegion></affiliation></author><author><name sortKey="Leonardi, Matilde" sort="Leonardi, Matilde" uniqKey="Leonardi M" first="Matilde" last="Leonardi">Matilde Leonardi</name><affiliation wicri:level="3"><nlm:affiliation>Neurology, Public Health, Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Neurology, Public Health, Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2021">2021</date><idno type="RBID">pubmed:34021772</idno><idno type="pmid">34021772</idno><idno type="doi">10.1007/s00415-021-10588-5</idno><idno type="pmc">PMC8140556</idno><idno type="wicri:Area/PubMed/Corpus">000008</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000008</idno><idno type="wicri:Area/PubMed/Curation">000008</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000008</idno><idno type="wicri:Area/PubMed/Checkpoint">000055</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000055</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review.</title><author><name sortKey="Garcia Azorin, David" sort="Garcia Azorin, David" uniqKey="Garcia Azorin D" first="David" last="García-Azorín">David García-Azorín</name><affiliation wicri:level="1"><nlm:affiliation>Headache Unit, Department of Neurology. Hospital, Clínico Universitario de Valladolid, Avenida Ramón y Cajal 3, 47005, Valladolid, Spain. dgazorin@ucm.es.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Headache Unit, Department of Neurology. Hospital, Clínico Universitario de Valladolid, Avenida Ramón y Cajal 3, 47005, Valladolid</wicri:regionArea><wicri:noRegion>Valladolid</wicri:noRegion></affiliation></author><author><name sortKey="Seeher, Katrin M" sort="Seeher, Katrin M" uniqKey="Seeher K" first="Katrin M" last="Seeher">Katrin M. Seeher</name><affiliation wicri:level="1"><nlm:affiliation>Department of Mental Health and Substance Use, World Health Organization, Geneve, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Mental Health and Substance Use, World Health Organization, Geneve</wicri:regionArea><wicri:noRegion>Geneve</wicri:noRegion></affiliation></author><author><name sortKey="Newton, Charles R" sort="Newton, Charles R" uniqKey="Newton C" first="Charles R" last="Newton">Charles R. Newton</name><affiliation wicri:level="4"><nlm:affiliation>Department of Psychiatry, University of Oxford, Oxford, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Psychiatry, University of Oxford, Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region></placeName><orgName type="university">Université d'Oxford</orgName></affiliation></author><author><name sortKey="Okubadejo, Njideka U" sort="Okubadejo, Njideka U" uniqKey="Okubadejo N" first="Njideka U" last="Okubadejo">Njideka U. Okubadejo</name><affiliation wicri:level="1"><nlm:affiliation>Neurology Unit, Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Neurology Unit, Department of Medicine, College of Medicine, University of Lagos, Lagos</wicri:regionArea><wicri:noRegion>Lagos</wicri:noRegion></affiliation></author><author><name sortKey="Pilotto, Andrea" sort="Pilotto, Andrea" uniqKey="Pilotto A" first="Andrea" last="Pilotto">Andrea Pilotto</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Brescia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Brescia</wicri:regionArea><wicri:noRegion>Brescia</wicri:noRegion></affiliation></author><author><name sortKey="Saylor, Deanna" sort="Saylor, Deanna" uniqKey="Saylor D" first="Deanna" last="Saylor">Deanna Saylor</name><affiliation wicri:level="2"><nlm:affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Winkler, Andrea Sylvia" sort="Winkler, Andrea Sylvia" uniqKey="Winkler A" first="Andrea Sylvia" last="Winkler">Andrea Sylvia Winkler</name><affiliation wicri:level="4"><nlm:affiliation>Centre for Global Health, Department of Neurology, Technical University of Munich, Munich, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Centre for Global Health, Department of Neurology, Technical University of Munich, Munich</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName><orgName type="university">Université Louis-et-Maximilien de Munich</orgName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Centre for Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway.</nlm:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Centre for Global Health, Institute of Health and Society, University of Oslo, Oslo</wicri:regionArea><placeName><settlement type="city">Oslo</settlement><region nuts="2">Østlandet</region></placeName></affiliation></author><author><name sortKey="Charfi Triki, Chahnez" sort="Charfi Triki, Chahnez" uniqKey="Charfi Triki C" first="Chahnez" last="Charfi Triki">Chahnez Charfi Triki</name><affiliation wicri:level="1"><nlm:affiliation>Child neurology department-Hedi Chaker Hospital, LR19ES 15-Sfax University, Sfax, Tunisia.</nlm:affiliation><country xml:lang="fr">Tunisie</country><wicri:regionArea>Child neurology department-Hedi Chaker Hospital, LR19ES 15-Sfax University, Sfax</wicri:regionArea><wicri:noRegion>Sfax</wicri:noRegion></affiliation></author><author><name sortKey="Leonardi, Matilde" sort="Leonardi, Matilde" uniqKey="Leonardi M" first="Matilde" last="Leonardi">Matilde Leonardi</name><affiliation wicri:level="3"><nlm:affiliation>Neurology, Public Health, Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Neurology, Public Health, Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author></analytic><series><title level="j">Journal of neurology</title><idno type="eISSN">1432-1459</idno><imprint><date when="2021" type="published">2021</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>The COVID-19 pandemic leads to disruptions of health services worldwide. To evaluate the particular impact on neurological services a rapid review was conducted.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Studies reporting the provision of neurological services during the pandemic and/or adopted mitigation strategies were included in this review. PubMed and World Health Organization's (WHO) COVID-19 database were searched. Data extraction followed categories used by WHO COVID-19 pulse surveys and operational guidelines on maintaining essential health services during COVID-19.</p></div><div type="abstract" xml:lang="en"><p><b>FINDINGS</b></p><p>The search yielded 1101 articles, of which 369 fulfilled eligibility criteria, describing data from 210,419 participants, being adults (81%), children (11.4%) or both (7.3%). Included articles reported data from 105 countries and territories covering all WHO regions and World Bank income levels (low income: 1.9%, lower middle: 24.7%, upper middle: 29.5% and high income; 44.8%). Cross-sectoral services for neurological disorders were most frequently disrupted (62.9%), followed by emergency/acute care (47.1%). The degree of disruption was at least moderate for 75% of studies. Travel restrictions due to lockdowns (81.7%) and regulatory closure of services (65.4%) were the most commonly reported causes of disruption. Authors most frequently described telemedicine (82.1%) and novel dispensing approaches for medicines (51.8%) as mitigation strategies. Evidence for the effectiveness of these measures is largely missing.</p></div><div type="abstract" xml:lang="en"><p><b>INTERPRETATION</b></p><p>The COVID-19 pandemic affects all aspects of neurological care. Given the worldwide prevalence of neurological disorders and the potential long-term neurological consequences of COVID-19, service disruptions are devastating. Different strategies such as telemedicine might mitigate the negative effects of the pandemic, but their efficacy and acceptability remain to be seen.</p></div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">34021772</PMID><DateRevised><Year>2021</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>May</Month><Day>22</Day></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-021-10588-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The COVID-19 pandemic leads to disruptions of health services worldwide. To evaluate the particular impact on neurological services a rapid review was conducted.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Studies reporting the provision of neurological services during the pandemic and/or adopted mitigation strategies were included in this review. PubMed and World Health Organization's (WHO) COVID-19 database were searched. Data extraction followed categories used by WHO COVID-19 pulse surveys and operational guidelines on maintaining essential health services during COVID-19.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">The search yielded 1101 articles, of which 369 fulfilled eligibility criteria, describing data from 210,419 participants, being adults (81%), children (11.4%) or both (7.3%). Included articles reported data from 105 countries and territories covering all WHO regions and World Bank income levels (low income: 1.9%, lower middle: 24.7%, upper middle: 29.5% and high income; 44.8%). Cross-sectoral services for neurological disorders were most frequently disrupted (62.9%), followed by emergency/acute care (47.1%). The degree of disruption was at least moderate for 75% of studies. Travel restrictions due to lockdowns (81.7%) and regulatory closure of services (65.4%) were the most commonly reported causes of disruption. Authors most frequently described telemedicine (82.1%) and novel dispensing approaches for medicines (51.8%) as mitigation strategies. Evidence for the effectiveness of these measures is largely missing.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">The COVID-19 pandemic affects all aspects of neurological care. Given the worldwide prevalence of neurological disorders and the potential long-term neurological consequences of COVID-19, service disruptions are devastating. Different strategies such as telemedicine might mitigate the negative effects of the pandemic, but their efficacy and acceptability remain to be seen.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>García-Azorín</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3132-1064</Identifier><AffiliationInfo><Affiliation>Headache Unit, Department of Neurology. Hospital, Clínico Universitario de Valladolid, Avenida Ramón y Cajal 3, 47005, Valladolid, Spain. dgazorin@ucm.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seeher</LastName><ForeName>Katrin M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Mental Health and Substance Use, World Health Organization, Geneve, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newton</LastName><ForeName>Charles R</ForeName><Initials>CR</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-6999-5507</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okubadejo</LastName><ForeName>Njideka U</ForeName><Initials>NU</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2975-8803</Identifier><AffiliationInfo><Affiliation>Neurology Unit, Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pilotto</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2029-6606</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saylor</LastName><ForeName>Deanna</ForeName><Initials>D</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9297-0244</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Andrea Sylvia</ForeName><Initials>AS</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3131-6983</Identifier><AffiliationInfo><Affiliation>Centre for Global Health, Department of Neurology, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Charfi Triki</LastName><ForeName>Chahnez</ForeName><Initials>C</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2918-3819</Identifier><AffiliationInfo><Affiliation>Child neurology department-Hedi Chaker Hospital, LR19ES 15-Sfax University, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Leonardi</LastName><ForeName>Matilde</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0552-8923</Identifier><AffiliationInfo><Affiliation>Neurology, Public Health, Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Health services administration</Keyword><Keyword MajorTopicYN="N">Nervous system diseases</Keyword><Keyword MajorTopicYN="N">Neurology</Keyword><Keyword MajorTopicYN="N">Telemedicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>04</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>04</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>22</Day><Hour>12</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34021772</ArticleId><ArticleId IdType="doi">10.1007/s00415-021-10588-5</ArticleId><ArticleId IdType="pii">10.1007/s00415-021-10588-5</ArticleId><ArticleId IdType="pmc">PMC8140556</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization Coronavirus (COVID-19) Dashboard. https://covid19.who.int Accessed 19 April 2021.</Citation></Reference><Reference><Citation>European mortality monitoring activity. Excess mortality. https://www.euromomo.eu/graphs-and-maps . Accessed 9 March 2021.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. Excess deaths associated with COVID-19. https://www.cdc.gov/mmwr/volumes/69/wr/mm6942e2.htm . Accessed 9 March 2021.</Citation></Reference><Reference><Citation>World Health Organization. The impact of COVID-19 on mental, neurological and substance use services: results of a rapid assessment. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO. https://www.who.int/publications/i/item/978924012455 . Accessed 9 March 2021.</Citation></Reference><Reference><Citation>French JA, Brodie MJ, Caraballo R et al (2020) Keeping people with epilepsy safe during the COVID-19 pandemic. Neurology 94(23):1032–1037. https://doi.org/10.1212/WNL.0000000000009632</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009632</ArticleId><ArticleId IdType="pubmed">32327490</ArticleId><ArticleId IdType="pmcid">7455365</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD (2019) Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30925-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Knauss S, Stelzle D, Emmrich JV, Korsnes MS, Sejvar JJ, Winkler AS (2019) An emphasis on neurology in low and middle-income countries. Lancet Neurol 18(12):1078–1079. https://doi.org/10.1016/S1474-4422(19)30392-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30392-8</ArticleId><ArticleId IdType="pubmed">31973806</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler AS (2020) The growing burden of neurological disorders in low-income and middle-income countries: priorities for policy making. Lancet Neurol 19(3):200–202. https://doi.org/10.1016/S1474-4422(19)30476-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30476-4</ArticleId><ArticleId IdType="pubmed">31813849</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Maintaining essential health services: operational guidance for the COVID-19 context interim guidance. https://www.who.int/publications/i/item/WHO-2019-nCoV-essential-health-services-2020.1 Accessed 8 April 2021.</Citation></Reference><Reference><Citation>von Oertzen TJ, Macerollo A, Leone MA, et al. EANcore COVID-19 task force (2021) EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic. Eur J Neurol 28(1):7-14. doi: https://doi.org/10.1111/ene.14521</Citation></Reference><Reference><Citation>Shamim-Uzzaman QA, Bae CJ, Ehsan Z et al (2021) The use of telemedicine for the diagnosis and treatment of sleep disorders: an American academy of sleep medicine update. J Clin Sleep Med. https://doi.org/10.5664/jcsm.9194</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.9194</ArticleId><ArticleId IdType="pubmed">33599202</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO guideline: recommendations on digital interventions for health system strengthening. World Health Organization 2019. https://apps.who.int/iris/bitstream/handle/10665/311941/9789241550505-eng.pdf?ua=1 . Accessed 9 March 2021.</Citation></Reference><Reference><Citation>WHO guideline: recommendations on digital interventions for health system strengthening. World Health Organization 2019. https://apps.who.int/iris/bitstream/handle/10665/311941/9789241550505-eng.pdf?ua=1 Accessed 9 March 2021.</Citation></Reference><Reference><Citation>Telemedicine: opportunities and developments in Member States: report on the second global survey on eHealth 2009. (Global Observatory for eHealth Series, 2). World Health Organization 2011. https://www.who.int/goe/publications/goe_telemedicine_2010.pdf Accessed 9 March 2021.</Citation></Reference><Reference><Citation>GBD (2019) Demographics Collaborators (2020) Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1160–1203. https://doi.org/10.1016/S0140-6736(20)30977-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30977-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. doi: https://doi.org/10.1371/journal.pmed.1000097</Citation></Reference><Reference><Citation>National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/mesh/68006298 Accessed 10 April 2021.</Citation></Reference><Reference><Citation>The World Bank Country and Lending Groups. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups . Accessed 10 April 2021.</Citation></Reference><Reference><Citation>Kontis V, Bennett JE, Rashid T et al (2020) Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries. Nat Med 26(12):1919–1928. https://doi.org/10.1038/s41591-020-1112-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1112-0</ArticleId><ArticleId IdType="pubmed">33057181</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme W, Dahake R, Delamou A et al (2020) The COVID-19 pandemic: diverse contexts; different epidemics-how and why? BMJ Glob Health 5(7):e003098. https://doi.org/10.1136/bmjgh-2020-003098</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2020-003098</ArticleId><ArticleId IdType="pubmed">32718950</ArticleId><ArticleId IdType="pmcid">7392634</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung K, Wu JT, Liu D, Leung GM (2020) First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment. Lancet 395(10233):1382–1393. https://doi.org/10.1016/S0140-6736(20)30746-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30746-7</ArticleId><ArticleId IdType="pubmed">32277878</ArticleId><ArticleId IdType="pmcid">7195331</ArticleId></ArticleIdList></Reference><Reference><Citation>Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S (2020) Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Sci Total Environ 730:138996. https://doi.org/10.1016/j.scitotenv.2020.138996</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2020.138996</ArticleId><ArticleId IdType="pubmed">32371230</ArticleId><ArticleId IdType="pmcid">7190497</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization COVID-19 observatory. Global epidemic curve, new confirmed cases. https://worldhealthorg.shinyapps.io/covid/ . Accessed 10 April 2021.</Citation></Reference><Reference><Citation>Leonardi M, Lee H, van der Veen S, et al (2020) Avoiding the Banality of Evil in Times of COVID-19: Thinking Differently with a Biopsychosocial Perspective for Future Health and Social Policies Development. SN Compr Clin Med 1-3. doi: https://doi.org/10.1007/s42399-020-00486-8</Citation></Reference><Reference><Citation>Altman DG, Bland JM (1995) Absence of evidence is not evidence of absence. BMJ 311(7003):485. https://doi.org/10.1136/bmj.311.7003.485</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.311.7003.485</ArticleId><ArticleId IdType="pubmed">7647644</ArticleId><ArticleId IdType="pmcid">2550545</ArticleId></ArticleIdList></Reference><Reference><Citation>Laxe S, Ferri J, Juárez-Belaunde A, Ríos-Lago M, Rodríguez-Duarte R, Murie-Fernández M (2020) Neurorehabilitation in the times of Covid-19: insights from the Spanish Neurorehabilitation Society (SENR). Brain Inj 34(12):1691–1692. https://doi.org/10.1080/02699052.2020.1830172</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02699052.2020.1830172</ArticleId><ArticleId IdType="pubmed">33104386</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceravolo MG, Arienti C, de Sire A, et al (2020) International multiprofessional steering committee of cochrane rehabilitation REH-COVER action. Rehabilitation and COVID-19: the cochrane rehabilitation 2020 rapid living systematic review. Eur J Phys Rehabil Med 56(5):642–51. doi: https://doi.org/10.23736/S1973-9087.20.06501-6 .</Citation></Reference><Reference><Citation>Leocani L, Diserens K, Moccia M, Caltagirone C; Neurorehabilitation Scientific Panel of the European Academy of Neurology-EAN (2020) Disability through COVID-19 pandemic: neurorehabilitation cannot wait. Eur J Neurol 27(9):e50-e51. doi: https://doi.org/10.1111/ene.14320</Citation></Reference><Reference><Citation>Sellner J, Jenkins TM, von Oertzen TJ, et al; EAN NeuroCOVID-19 Task Force (2021) A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology. Eur J Neurol doi: https://doi.org/10.1111/ene.14741</Citation></Reference><Reference><Citation>Pareyson D, Pantaleoni C, Eleopra R, et al, for the Besta-Telehealth Task Force (2021) Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy. Neurolol Sci doi: https://doi.org/10.1007/s10072-021-05252-9 .</Citation></Reference><Reference><Citation>World Health Organization. Atlas of Mental Health disorders. https://www.who.int/publications/i/item/atlas-country-resources-for-neurological-disorders . Accessed 10 April 2021.</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li><li>Espagne</li><li>Italie</li><li>Nigeria</li><li>Norvège</li><li>Royaume-Uni</li><li>Suisse</li><li>Tunisie</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Bavière</li><li>District de Haute-Bavière</li><li>Lombardie</li><li>Maryland</li><li>Oxfordshire</li><li>Østlandet</li></region><settlement><li>Milan</li><li>Munich</li><li>Oslo</li><li>Oxford</li></settlement><orgName><li>Université Louis-et-Maximilien de Munich</li><li>Université d'Oxford</li></orgName></list><tree><country name="Espagne"><noRegion><name sortKey="Garcia Azorin, David" sort="Garcia Azorin, David" uniqKey="Garcia Azorin D" first="David" last="García-Azorín">David García-Azorín</name></noRegion></country><country name="Suisse"><noRegion><name sortKey="Seeher, Katrin M" sort="Seeher, Katrin M" uniqKey="Seeher K" first="Katrin M" last="Seeher">Katrin M. Seeher</name></noRegion></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Newton, Charles R" sort="Newton, Charles R" uniqKey="Newton C" first="Charles R" last="Newton">Charles R. Newton</name></region></country><country name="Nigeria"><noRegion><name sortKey="Okubadejo, Njideka U" sort="Okubadejo, Njideka U" uniqKey="Okubadejo N" first="Njideka U" last="Okubadejo">Njideka U. Okubadejo</name></noRegion></country><country name="Italie"><noRegion><name sortKey="Pilotto, Andrea" sort="Pilotto, Andrea" uniqKey="Pilotto A" first="Andrea" last="Pilotto">Andrea Pilotto</name></noRegion><name sortKey="Leonardi, Matilde" sort="Leonardi, Matilde" uniqKey="Leonardi M" first="Matilde" last="Leonardi">Matilde Leonardi</name></country><country name="États-Unis"><region name="Maryland"><name sortKey="Saylor, Deanna" sort="Saylor, Deanna" uniqKey="Saylor D" first="Deanna" last="Saylor">Deanna Saylor</name></region></country><country name="Allemagne"><region name="Bavière"><name sortKey="Winkler, Andrea Sylvia" sort="Winkler, Andrea Sylvia" uniqKey="Winkler A" first="Andrea Sylvia" last="Winkler">Andrea Sylvia Winkler</name></region></country><country name="Norvège"><region name="Østlandet"><name sortKey="Winkler, Andrea Sylvia" sort="Winkler, Andrea Sylvia" uniqKey="Winkler A" first="Andrea Sylvia" last="Winkler">Andrea Sylvia Winkler</name></region></country><country name="Tunisie"><noRegion><name sortKey="Charfi Triki, Chahnez" sort="Charfi Triki, Chahnez" uniqKey="Charfi Triki C" first="Chahnez" last="Charfi Triki">Chahnez Charfi Triki</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/MaghrebDataLibMedV2/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000055 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000055 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= MaghrebDataLibMedV2
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:34021772
|texte= Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:34021772" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a MaghrebDataLibMedV2
| This area was generated with Dilib version V0.6.38. |  |